Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00152165 · ClinicalTrials.gov registry record

Use of Radiostereometric Analysis (RSA) Following Spinal Fusion Versus the DYNESYS Stabilization System

A clinical trial, sponsored by State University of New York - Upstate Medical University.

Completed
Registry status
12
Enrollment target

NCT00152165 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00152165 has completed, sponsored by State University of New York - Upstate Medical University.

COMPLETED
Registry status
12 participants
Enrollment target

Study Summary

Twelve subjects will be sought for this study. Six subjects will receive the DYNESYS system and six subjects will receive a posterior lumbar interbody fusion (PLIF) with the Silhouette device. All subjects will already be participating in the DYNESYS multi-center study (under IRB #4884) and will have been randomized to either group. Five tantalum beads will be inserted into each vertebra associated with the DYNESYS or fusion surgery. Subjects will be followed in conjunction with the multi-center follow-up schedule and will have RSA exams at the following time points after surgery: 3, 6, 12, 18, and 24 months. Standing neutral, flexion, extension, and lateral bending films will be collected at each time point and the amount of motion in each direction of the "marked" vertebrae will be measured. The time points have been selected based on their clinical relevance for comparison against the standard of care, which is the fusion procedure. Depending on the initial tension of the annular fibers, it is possible the DYNESYS will exhibit more motion with time. The time points are important to track the potential changes.

Interventions

  • PROCEDURE Radiostereometric Analysis beads inserted during surgery

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2003-11

What the Registry Record Tells You About NCT00152165

The ClinicalTrials.gov registry entry for NCT00152165 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Radiostereometric Analysis beads inserted during surgery is the first listed.

NCT00152165 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00152165 about?

NCT00152165 is a clinical study titled "Use of Radiostereometric Analysis (RSA) Following Spinal Fusion Versus the DYNESYS Stabilization System". Twelve subjects will be sought for this study. Six subjects will receive the DYNESYS system and six subjects will receive a posterior lumbar interbody fusion (PLIF) with the Silhouette device. All subjects will already be participating in the DYNESYS multi-center study (under IRB #4884) and will hav...

What is the current status of trial NCT00152165?

This trial is currently completed. The enrollment target is 12 participants. The study started on 2003-11.

What interventions are being tested in trial NCT00152165?

The interventions under investigation include: Radiostereometric Analysis beads inserted during surgery (PROCEDURE).

Who is sponsoring clinical trial NCT00152165?

This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.